Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-104202

Chief Financial Officer acquired 800 shares (grant or award)

  • Chief Financial Officer gave up 143 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2024-09-03 Shares withheld for taxes −143 $35.30 $5,048 11,718 D
Mokari Atabak Chief Financial Officer 2024-09-03 Grant or award +400 $34.26 $13,704 12,118 D
Mokari Atabak Chief Financial Officer 2024-09-03 Grant or award +400 12,518 D
Loading xslF345X05/ownership.xml…